Your browser doesn't support javascript.
loading
A Comprehensive Multidisciplinary Diagnostic Algorithm for the Early and Efficient Detection of Amyloidosis.
Jimenez-Zepeda, Victor; Bril, Vera; Lemieux-Blanchard, Emilie; Royal, Virginie; McCurdy, Arleigh; Schwartz, Daniel; Davis, Margot K.
Afiliação
  • Jimenez-Zepeda V; Department of Hematology, University of Calgary and Arnie Charbonneau Cancer Institute, Calgary, Alberta, Canada. Electronic address: victor.zepeda@ahs.ca.
  • Bril V; Division of Neurology, Department of Medicine, University of Toronto and University Health Network, Toranto, Ontario, Canada.
  • Lemieux-Blanchard E; Department of Hematology, Service d'hématologie-oncologie du Centre hospitalier de l'Université de Montréal and Centre de recherche du CHUM, Montreal, Quebec, Canada.
  • Royal V; Department of Pathology, Hôpital Maisonneuve-Rosemont, Université de Montreal, Montreal, Quebec, Canada.
  • McCurdy A; Division of Hematology, The Ottawa Hospital and University of Ottawa, Ottawa, Ontario, Canada.
  • Schwartz D; Faculty of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Davis MK; Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
Clin Lymphoma Myeloma Leuk ; 23(3): 194-202, 2023 03.
Article em En | MEDLINE | ID: mdl-36653205
ABSTRACT
Amyloidosis is a rare protein misfolding disease caused by the accumulation of amyloid fibrils in various tissues and organs. There are different subtypes of amyloidosis, with light chain (AL) amyloidosis being the most common. Amyloidosis is notoriously difficult to diagnose because it is clinically heterogeneous, no single test is diagnostic for the disease, and diagnosis typically involves multiple specialists. Here, we propose an integrated, multidisciplinary algorithm for efficiently diagnosing amyloidosis. Drawing on research from several medical disciplines, we have combined clinical decisions and best practices into a comprehensive algorithm to facilitate the early detection of amyloidosis. Currently, many patients are diagnosed more than 6 months after symptom onset, yet early diagnosis is the major predictor of survival. Our algorithm aims to shorten the time to diagnosis with efficient sequencing of tests and minimizing uninformative investigations. We also recommend typing and staging of confirmed amyloidosis to guide treatment. By reducing time to diagnosis, our algorithm could lead to earlier and more targeted treatment, ultimately improving prognosis and survival.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article